CAMBRIDGE, Mass.--(BUSINESS WIRE)--
Medicine, Inc. (NASDAQ:FMI) today announced that members of the
company's management team will present at the following upcoming
Michael J. Pellini, M.D., president and chief executive officer, will
present at the Goldman Sachs Global Healthcare Conference onWednesday, June 11, 2014 at 4:00 p.m. P.T. in Rancho Palos Verdes, CA.
Steven J. Kafka, Ph.D., chief operating officer, will present at the
JMP Securities Healthcare Conference on Tuesday, June 24, 2014 at 3:00
p.m. E.T. in New York, NY.
Live, listen-only webcasts of the presentations may be accessed by
visiting the investors section of the company's website at investors.foundationmedicine.com.
A replay of each webcast will be available shortly after the conclusion
of the presentation and will be archived on the company's website for
two weeks following each presentation.
About Foundation Medicine
Foundation Medicine (NASDAQ: FMI) is a molecular information company
dedicated to a transformation in cancer care in which treatment is
informed by a deep understanding of the genomic changes that contribute
to each patient's unique cancer. The company's clinical assays,
FoundationOne for solid tumors and FoundationOne Heme for hematologic
malignancies, sarcomas and pediatric cancers, provide a fully
informative genomic profile to identify the molecular alterations in a
patient's cancer and match them with relevant targeted therapies and
clinical trials. Foundation Medicine's molecular information platform
aims to improve day-to-day care for patients by serving the needs of
clinicians, academic researchers and drug developers to help advance the
science of molecular medicine in cancer. For more information, please
or follow Foundation Medicine on Twitter (@FoundationATCG).
Foundation Medicine® and FoundationOne®
are registered trademarks of Foundation Medicine, Inc.
Pure Communications, Inc.
Foundation Medicine, Inc.
Source: Foundation Medicine, Inc.
News Provided by Acquire Media